As a novel delocalized lipophilic cation, F16 selectively accumulates in mitochondria of carcinoma cells and shows a broad spectrum of antiproliferative action towards cancer cell lines. In order to reveal the mode of action and molecular mechanism of F16 inducing cytotoxicity, we investigated the effects of F16 on cancer cells and isolated mitochondria relative to its precursor compound (E)-3-(2-(pyridine-4yl)vinyl)-1 H-indole (PVI), which has a similar structure without positive charge. It was found that PVI did not accumulate in mitochondria, and exhibited lower cytotoxicity compared to F16. However, when they were directly incubated with mitochondria, both F16 and PVI were observed to induce damage to mitochondrial structure and function. Moreover, it was found that F16 as well as PVI acted as uncouplers on mitochondria, and further rescue experiments revealed that the addition of adenosine 5 0 -triphosphate was the most effective way to recover the cell viability decreased by F16. Thus it was concluded that the decreased intracellular adenosine 5 0 -triphosphate availability induced by the uncoupling effect of F16 was a major factor in F16-mediated cytotoxicity. Futhermore, the results indicated that the uncoupling effect of F16 is attributed to its chemical stucture in common with PVI but independent of its positive charge. The study may shed light on understanding the underlying mechanism of action for F16, and providing suggestions for the design of new mitochondria-targeted antitumor molecules.
(ATP), mitochondria perform pivotal biochemical functions necessary for homeostasis and are arbiters of cell death and survival (Wallace, 2005) . Moreover, mitochondria and the reactions taking place within the organelle occupy a central position on a series of metabolic chart, eg, Krebs' cycle, urea cycle and fatty acid oxidation (Scheffler, 2001) . When compared with normal cells, mitochondria in cancer cells exhibit low oxidative phosphorylation, high transmembrane potential, increased reactive oxygen species (ROS) and deregulated mitochondrial apoptotic pathway (Fantin and Leder, 2006) . These features could be exploited for the development of selective anticancer therapeutics.
Delocalized lipophilic cations (DLCs) are a family of compounds that penetrate the hydrophobic barriers of the plasma and mitochondrial membranes, accumulating in mitochondria driven by the negative transmembrane potential. At high concentrations, DLCs are toxic to mitochondria and may lead to tumor cell death, suggesting a rationale for the selective chemotherapy of cancer cells. F16 ((E)-4-(1 H-indol-3-ylvinyl)-Nmethylpyridinium iodide) as a novel DLC was first screened from approximately 16 000 small molecules by Fantin et al. (2002) through a high throughput screen for inhibitors that selectively interfere with the proliferation of neu-overexpressing cells. F16 mainly concentrated in mitochondrial matrix and showed a broad spectrum of antiproliferative action toward cancer cell lines. The mitochondrial dysfunction caused by F16 was related to induction of mitochondrial permeability transition (MPT). Further study showed that the overexpression of Bcl-2 oncogene inducing resistance of cancer cells did not prevent F16-induced necrosis resulting from an energetic, ionic, and redox catastrophe (Fantin and Leder, 2004) . These studies make F16 an attractive and promising mitochondria-targeted anticancer small molecule, but unfortunately, subsequent reports are few. Thus the toxicity mechanism of F16 remains unclear.
PVI ((E)-3-(2-(pyridine-4yl)vinyl)-1 H-indole), the precursor compound used for synthesizing F16, almost has the same chemical structure as F16 except for lacking of a methyl and a positive charge (seen in Figure 1 ). We have already figured out that the difference in structure would affect binding interactions with human serum albumin (HSA), resulting in different thermodynamic properties related to absorption, transportation, distribution, metabolism as well as altering drug efficacy (Wang et al., 2014) .
Recently, mitochondria are emerging as targets for a variety of anticancer drugs (Dias and Bailly, 2005; Fulda et al., 2010; Indran et al., 2011; Neuzil et al., 2013) . Triphenylphosphonium (TPP) cation, one member of the DLCs family, is widely used as a probe for the investigation of mitochondrial function and to take other agents into mitochondria (Dong et al., 2011; Jara et al., 2014; Pathak et al., 2014; Ross et al., 2005) . When compared with TPP, the study of F16 is rare, while there are several good features of F16. In addition to the antiproliferative effect on tumor cells, F16 is a fluorescent small molecule, and it can be linked with other agents to monitor the uptake by cells and the localization. Overall, more attention and further studies are necessary for this promising small molecule.
In this study, we focused on toxicity of F16 and PVI on cultured cells and isolated mitochondria. Effects on tumor cells upon the treatment of F16 and PVI were investigated, and important signs of MPT were monitored, to reveal how F16 and PVI induce cytotoxicity. Considering the structure connections between F16 and PVI, the control experiments will be helpful to acquire the relationship between anticancer mechanism of F16 and its chemical structure. The study will benefit the development of new mitochondria-targeted antitumor molecules.
MATERIALS AND METHODS
Chemicals and reagents. F16 and PVI were synthesized and characterized as our previous report (Wang et al., 2014) . Bovine serum albumin, rotenone, oligomycin, sodium pyruvate, rhodamine123 (Rh123), hematoporphyrin (HP), ethylene diamine tetraacetic acid (EDTA), cyclosporin A (Cs A), ruthenium red (RR), adenosine 5 0 -diphosphate (ADP) sodium salt, ATP disodium salt hydrate, dithiothreitol (DTT), glutathione (GSH), Nacetylcysteine (NAC), vitamin C (VC), 2, 4-dinitrophenol (DNP), carbonyl cyanide p-trifluoro-methoxyphenylhydrazone (FCCP), carbonyl cyanide 3-chlorophenylhydrazone (CCCP), and propidium iodide (PI) were purchased from Sigma (MO, USA); Dulbecco's modified Eagle's medium (DMEM) and fetal bovine serum (FBS) were purchased from Gibco (MA, USA); 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) was purchased from Aladdin (Shanghai, China); MitoTracker Red CM-H 2 XRos and Hoechst 33342 were purchased from Invitrogen (MA, USA); ZVAD-fmk and necrostatin-1 (Nec-1) were purchased from ApexBio (MA, USA); Annexin V PE Apoptosis Detection Kit was purchased from eBioscience (MA, USA); dihydroethidium (DHE) and ATP Assay Kit were purchased from Beyotime (Shanghai, China); Rat Cytochrome c ELISA Kit was purchased from Novateinbio (MA, USA). All other reagents were of analytical reagent grade, and all solutions were prepared with aseptic double-distilled water. Double-distilled water was prepared from a Milli-Q-RO4 water purification system (Milipore, Darmstadt, Germany). In rescue experiments, ZVAD-fmk, Nec-1, DTT, GSH, NAC, and VC were added 2 h before the addition of F16 or PVI; Cs A was added 4 h after the addition of F16 or PVI; EDTA, RR, ADP, and ATP were added 0.5 h before the addition of F16 or PVI; glucose (Gluc) was added 3 h before the addition of F16 or PVI.
Detection of apoptosis and cell cycle. SGC-7901 cells untreated or treated with various concentrations of F16 for 24 h or with PVI (B) for 48 h were stained with AnnexinV-PE and 7-AAD following manufacturer's procedure. The labeled cells were analyzed by BD Accuri C6 flow cytometry (Becton Dickinson, NJ, USA).
In cell cycle assay, SGC-7901 cells were seeded in 6-well plate. After adhering to the surface of wells, cells were serum starved for 36 h to arrest them in G0 phase of the cell cycle, then they were treated with various concentrations of F16 or PVI in DMEM complete medium for 24 h. Next cells were collected and fixed in 70% ethanol at 4 C overnight. Finally, cells were stained with PI for 15 min and analyzed by flow cytometry.
Measurement of intracellular oxidation level. Cells were grown in the absence or in the presence of F16 or PVI for 48 h. Then cells were incubated in PBS with 5 mM DHE or 1 mM MitoTracker Red CM-H 2 XRos at 37 C for 30 min. Next cells were collected and resuspended in PBS and immediately analyzed by flow cytometry.
To investigate the recovery of the increasing level of intracellular oxidants upon the treatment of F16, DTT, GSH, NAC and VC were added 2 h before the addition of F16. Cells were grown for 48 h, then stained with DHE or MitoTracker Red CM-H 2 XRos and analyzed by flow cytometry.
Localization of F16 and PVI in cells. Cells were incubated with medium containing 3 lM F16 or 30 lM PVI for 24 h. MitoTracker Red CM-H 2 XRos was added to the medium to stain mitochondria according to manufacturer's procedure, and Hoechst 33342 was included to stain nuclei. The fluorescent signal was observed by Eclipse C1-si laser scanning confocal microscope (Nikon, Tokyo, Japan) using an (60Â) immersion oil objective.
Determination of intracellular ATP. Intraellular ATP levels were determined by luciferin-luciferase method. Cells were grown in the absence or in the presence of F16 or PVI for 48 h. As positive control, cells were treated with 50 mM DNP or 2 mM CCCP for 48 h. Then cells were harvested and lysed according to manufacturer's procedure.
Isolation of mitochondria. Wistar rats (200-250 g) were purchased from Hubei Research Centre of Experimental Animals (Wuhan, China). Rat liver mitochondria were isolated by standard differential centrifugation according to the literature with minor modifications (Liu et al., 2011; Xia et al., 2002) . The concentration of mitochondrial protein was measured by the Biuret method. All operations were performed at 0 C-4 C. The respiratory control ratio (RCR) was measured by a Clark-type electrode (Oxygraph; Hansatech, King's Lynn, UK) according to Li et al. (2012) , and only mitochondrial suspensions with a RCR above 3.0 were used as experimental materials.
Mitochondrial ultrastructure. Observations of mitochondrial ultrastructure were performed with a JEM-100CX II transmission electron microscope (TEM) (JEOL, Tokyo, Japan). Mitochondria under various experimental conditions were fixed for 30 min at 4 C using glutaraldehyde at a final concentration of 2.5% (v/v) in PBS buffer, then the micropellets were postfixed with 1% (w/v) osmium tetroxide and dehydrated (Petronilli et al., 2009) .
Mitochondrial swelling, H1/K1 permeabilization and membrane fluidity. Mitochondrial swelling was measured spectrophotometrically by monitoring the absorbance at 540 nm over 7 min at 25 C by UNICO 4802 UV-vis Double Beam Spectrophotometer (Dayton, NJ, USA). Mitochondria were suspended in 2 ml respiration buffer B (200 mM sucrose, 10 mM Tris-Mops, 20 lM EGTATris, 5 mM succinate, 2 lM rotenone and 3 lg ml À1 oligomycin, pH 7.4), and 2.5 lM Ca 2þ was added before injecting F16 or PVI.
Mitochondrial inner membrane permeabilizations to H
þ and K þ were measured by alterations of absorbance at 540 nm.
The H þ assay solution contained 135 mM K-acetate, 5 mM HEPES, 0.1 mM EGTA, 0.2 mM EDTA, 1 lg ml À1 valinomycin and 2 lM rotenone, and the K þ assay solution contained 135 mM KNO 3 , 5 mM HEPES, 0.1 mM EGTA, 0.2 mM EDTA and 2 lM rotenone. Mitochondrial membrane fluidity was measured by the fluorescence anisotropy changes of hematoporphrin (HP)-labeled mitochondria by an LS-55 fluorophotometer (Perkin Elmer, MA, USA) according to Braguini et al. (2004) . Fluorescence anisotropic (r) values were collected by measurement of I \ and I || , ie, the fluorescence intensities polarized parallel and perpendicular, respectively, at 626 nm (k ex ¼ 520 nm), defining by the equation
Where G ¼ I \ /I || is the correction factor for instrumental artifacts (Ricchelli et al., 1999; Lakowicz, 2006) . Free probes in the bulk medium do not contribute to the fluorescence anisotropy since they are almost fluorimetrically silent in aqueous media. The assay solution contained 0.2 M sucrose, 10 mM Tris, 10 mM Mops, 1 mM Na 3 PO 4 Á10H 2 O, 10 mM EGTA, 3 mg ml À1 oligomycin and 5 mM succinate, supplemented with 2 lM rotenone, pH 7.2. All operations were performed at 25 C.
Oxygen consumption. All oxygen consumption measurements were made using a Clark-type electrode in a 1-ml thermostatted, water-jacketed glass chamber maintained at 25 C (Monteiro et al., 2008) . For mitochondrial respiration measurement, mitochondria were suspended in respiration buffer E (100 mM sucrose, 10 mM Tris-Mops, 1 mM EDTA, 50 mM KCl, 2 mM MgCl 2 , 10 mM KH 2 PO 4 and 2 lM rotenone, pH 7.4) in a sealed chamber equipped with a magnetic stirrer. Five respiratory states of isolated mitochondria can be distinguished according to Chance and Williams (1955) . In state 3, all components are available in excess, while state 4 indicates high oxygen and high substrate levels but low ADP levels. Since a high state 3 rate indicates an intact respiratory chain and ATP synthesis, while a low state 4 rate indicates an intact mitochondrial inner membrane (Adlam et al. 2005) , state 4 was considered upon addition of 5 mM succinate as the energizing substrate, and 0.3 mM ADP was added subsequently to induce state 3 respiration.
Microcalorimetric determination of mitochondrial metabolism. The metabolic thermogenic curves of isolated mitochondria were performed at 37 C using a TAM III Isothermal Calorimeter (TA Instruments, DE, USA) with ampoule method. Each sealed ampoule contained 1.0 ml of sample and 3.0 ml of air, providing sufficient O 2 for the mitochondrial metabolism. Each sample contained 200 ml mitochondrial suspension and 15 mM sodium pyruvate as respiration substrate in the absence or in the presence of 20 mM F16, 20 mM PVI, 50 mM DNP or 2 mM CCCP. The assay buffer contained 0.22 M mannitol, 0.07 M sucrose and 1 mM EDTA, pH 7.4.
Mitochondrial membrane potential. Changes in mitochondrial membrane potential (DW m ) were indicated by the accumulation of Rh123 (250 mM) as monitored by the changes in fluorescence emission intensity at 25 C (k ex ¼ 488 nm, k em ¼ 525 nm) according to Zamzami et al. (1995) . Mitochondria were suspended in buffer B. The change in fluorescence intensity induced by FCCP was used as a standard of maximum depolarization, and other data were expressed as percentage.
Cytochrome c release. In total 500 lM mitochondria and different concentrations of F16 or PVI were suspended into 1.5 ml buffer solution and incubated under 4 C for 1 h. Then samples were centrifuged at 17 500 Â g for 5 min and the supernatant were obtained. The content of cytochrome c was determined by Rat Cytochrome c ELISA Kit in accordance with the manufacturer's instruction. The absorbance at 450 nm was recorded on a microtiter plate reader (Tecan, Salzburg, Austria).
RESULTS

Cytotoxicity of F16 and PVI
In order to compare the cytotoxic ability of F16 and PVI, we chose four cell lines. Two tumor cell lines (SGC-7901 and MCF-7), and two nontumor-derived cell lines (GES-1 and HEK-293). As the result shown in Table 1 Annexin V-PE in conjunction with the viability dye 7-AAD were used to stain cells and monitored by flow cytometry to indicate cell death (Figs. 1A and B) . Early apoptosis was expressed as the percentage of PEþ/7-AADÀ, late apoptosis and necrosis were expressed as PEþ/7-AADþ and PE-/7-AADþ. F16 with increasing concentration resulted in a decrease in viable, nonapoptotic cells (PE-/7-AADÀ) and an increase in the Annexin V-PE positive cell population ( Figure 1A ), indicating that cells were undergoing apoptosis. In accordance with MTT assay, PVI did not induce obvious apoptosis in SGC-7901 cells in the conditions examined ( Figure 1B) .
Different from previous report that F16 caused G1 arrest in EpH4-A6 cells (Fantin et al., 2002) , we found that F16 induced an increase in the number of cells in S phase in SGC-7901 cells ( Figure 1C ). The discrepancy may be attributed to the different cell lines. PVI did not induce a significant cell cycle arrest in SGC-7901 cells ( Figure 1D ).
Mitochondria are an important source of ROS within most mammalian cells. The production of ROS by mitochondria underlies oxidative damage in many pathologies, and contributes to retrograde redox signaling from the organelle to the cytosol and nucleus (Murphy, 2009 ). Therefore we measured the intracellular ROS level following treatment with F16 or PVI. An increase in ROS production could be detected by monitoring the conversion of DHE to ethidium by flow cytometry. The addition of F16 resulted in a right shift of the fluorescent signal peak (Figure 2A ), indicating higher levels of ROS. MitoTracker Red CM-H 2 XRos is a fixable mitochondrion-selective dye, but it does not fluoresce in its original state. Instead, it is oxidized to the corresponding fluorescent probe after entering live cells, and then sequestered in the mitochondria. Therefore this dye can also be used to determine the level of intracellular ROS (Kuznetsov et al., 2011) . Similar increasing fluorescent signals of MitoTracker Red CM-H 2 XRos were observed following the treatment of F16 ( Figure 2C ). PVI caused a smaller effect on the level of intracellular oxidants compared to F16, as shown by DHE and MitoTracker Red CM-H 2 XRos (Figs. 2B and D) . We also added several reductants to find out if they could recover the increasing level of intracellular ROS upon the treatment of F16 (Supplementary Figure 3) . The performance of these agents were different. In general, the reductants could partially recover the increase in fluorescent signal caused by F16.
Cellular localization is important as it may indicate the position and direct target of agents entering cells. Because PVI has much lower UV absorption and fluorescence emission intensity than F16 (Supplementary Figure 1) , the dose of PVI was 10-fold of that of F16 to make the fluorescence intensity of PVI comparable with that of F16. It was not surprising to observe that F16 mainly accumulated in mitochondria as its fluorescence well overlapped with the mitochondrion-selective dye MitoTracker Red CM-H 2 XRos ( Figure 3A ). This is identical with previous report (Fantin et al., 2002) . What noticeable was the subcellular site of PVI. As shown in Figure 3B , instead of in mitochondria PVI seemed to accumulate somewhere in cytoplasmic matrix. We could not define whether PVI had a specific target site inside the cells from this experiment. That might give a reason for less toxicity of PVI on cultured tumor cells.
Inducing Mitochondrial Dysfunction
The effects of F16 on mitochondrial structure can be observed intuitively by TEM as reported by Fantin et al. (2002) . In order to make the experimental results from isolated mitochondria were comparable to those from cultured cells, we used higher doses of F16 in the experiments performed on isolated mitochondria. As shown in Figure 4A , mitochondria isolated from rat liver without drug treatment exhibited normal shape, integrated structure, well-defined outer membrane, narrow inter membrane space, rich cristae and dense matrix. After treatment with 10 lM F16 ( Figure 4B ), an obvious swelling was observed, with decreased matrix electron density, enlarged volume and blurred outer membrane. Treatment with higher concentration of F16 resulted in outer membrane rupturing and the loss of typical pattern of inner membrane folding ( Figure 4C ). PVI at the concentration of 10 lM did not cause an apparent change in mitochondrial structure ( Figure 4D ). However, a striking swelling was observed when the concentration increased to 50 lM ( Figure 4E ). Swelling is a hallmark of mitochondrial dysfunction and one of the most important indicators of the MPT pore opening (Gerencser et al., 2008) . As shown in Figures 4F and 4G , treatment with F16 or PVI induced mitochondrial matrix swelling in a time and dose dependent manner. Interestingly, with the addition of F16, mitochondrial absorbance at 540 nm exhibited an increase before decreasing. The lower concentration (10-50 lM) of PVI did not induce obvious swelling, while the absorbance declined acutely at the concentration of 75 lM. Mitochondrial inner membrane has strict control of the ions permeabilization, as it plays important roles in sustaining homeostasis and keeping normal function of mitochondria. H þ contributes to the ATP synthesis, and K þ is related to the control of mitochondrial swelling and membrane potential. The potassium channels most likely play a dominant role in mitochondrial volume control and in the maintenance of the architecture of the inner membrane and the intermembrane space (IMS) (Scheffler, 2001) . The effects of F16 and PVI on mitochondrial inner membrane permeabilization to H þ and K þ were similar (Supplementary Figure 4) . The absorbance was reduced with increasing addition of F16 or PVI, indicating an enhanced permea-
The changes in H þ and K þ levels might disrupt the DW m , further leading to the collapse of DW m and the disorder of mitochondrial respiration. As a biological membrane probe, HP can targetly bind on MPT pore constituents in mitochondria, thus the fluorescence anisotropy change of HP can reveal not only the change of mitochondrial membrane fluidity, but also the conformational variation of MPT pore. As shown in Supplementary Figure 5 , with the addition of F16, the anisotropy reduced immediately, while PVI exhibited a slow but long-term impact. Both PVI and F16 increased mitochondrial membrane fluidity.
Totally, the effects of F16 and PVI on isolated mitochondria were much more similar than those on cultured cells. Without positive charge, PVI could not selectively accumulated in mitochondria, which weakened its cytotoxicity. But PVI still had effects on mitochondria, and the effects could be striking with efficient dose and proper treating time. Figures 5A and 5B shows a Clark-type oxygen-sensitive electrode determination of oxygen consumption in mitochondria energized with the complex II substrate succinate. With the addition of F16 or PVI, the state 3 respiration did not change much, while the respiration rate of state 4 increased in a dosedependent manner. At the concentration of 75 mM, the respiration rate of state 4 were approximately 3-fold of the controls. The stimulation for state 4 respiration indicated that F16 and PVI might have uncoupling effects on mitochondria (Terada, 1990) , thus further experiments were carried out to confirm. ATP is synthesized by coupling two reactions in mitochondria, i. e. electron transport and phosphorylation. Uncouplers can inhibit ATP synthesis by preventing this coupling reaction, thus the energy produced by redox reactions cannot be used for phosphorylation, but producing heat instead. We utilized microcalorimetric method to evaluate the energy released from mitochondria in the presence of F16 or PVI. The result is shown in Figure 5C . The thermogenic curve of energized mitochondria can be divided into 3 phases: activity recovery phase, stationary increase phase, and decline phase. In activity recovery phase, the heat output curve started rapidly and the energy released from mitochondria increased sharply with the addition of pyruvate as the energized-substrate, producing a logarithmic curve. Then the stationary increase phase was observed. When nutrients of the mitochondria and oxygen in the ampoule were exhausted, the curve entered the decline phase (Xia et al. 2013) . The thermokinetic equation can be expressed as following: lnP t ¼ lnP 0 þ kt: P 0 and P t are the heat output power at time 0 and time t, respectively. k stands for rate constant. The rate constant of the activity recovery phase is k 1 , and Àk 2 is designated for the decline phase. With the addition of F16 or PVI, the k 1 increased, as well as the maximum heat output (P m ), resulting in a rising total heat output (Q) as listed in Table 2 . The influence of F16 and PVI on the metabolic activities of isolated mitochondria was similar to that of classic uncouplers DNP and CCCP, verifying the uncoupling effect of F16 and PVI.
Uncoupling Effects on Mitochondria
The uncoupling effect of F16 and PVI on mitochondria is expected to induce a decrease in intracellular ATP content. Therefore ATP concentration in F16-or PVI-treated SGC-7901 cells was determined by the luciferase-catalyzed ATP-dependent bioluminescent oxidation of luciferin (Fantin et al., 2002) . DNP and CCCP were used as positive controls. F16 resulted in significantly decreased ATP levels, and it seemed that a higher concentration would not enhance effect. PVI at high concentrations also reduced the intracellular ATP content (Figure 6 ). 
Decrease of DW m and Cytochrome c Release
In mitochondria ATP synthesis is closely related to the membrane potential (DW m ), and decreased DW m is widely used as an early measure of cell death. Here DW m was represented by fluorescence intensity of Rh123. As a DLC, Rh123 can selectively accumulate in mitochondrial matrix, accompanied by fluorescence quenching. Upon collapse of DW m , Rh123 is released into the medium with a recovery of fluorescence. As shown in Figure 7A , with the increasing addition of F16, the fluorescence intensity of Rh123 increased gradually. The existence of Cs A effectively blunted the effect, indicating that the decrease of DW m induced by F16 was related to MPT. Although in the presence of PVI, the fluorescence recovery was not significant (Figure 7B ), suggesting a less influence of PVI on DW m.
Cytochrome c is one of the IMS proteins released from mitochondrial IMS into cytosol resulting from mitochondrial outer membrane permeabilization (MOMP). It sets in motion a series of biochemical events that mediate the execution phase of the cell death program (Fantin and Leder, 2006) . The release of cytochrome c in the presence of F16 or PVI is shown in Figure 7C . When compared with the control, F16 as well as PVI could induce increasing cytochrome c release, and F16 showed a more dramatic effect than PVI did.
Rescue Experiments
Rescue experiments were designed to find out the direct factor that result in cytotoxicity induced by F16 in SGC-7901 cells. The protective agents utilized could be classified to 4 types. The first type included the broad-spectrum caspase inhibitor ZVAD-fmk and the receptor-associated adaptor kinase RIP1 inhibitor Nec-1, which is identified as an inhibitor of regulated necrotic cell death (necroptosis) (Degterev et al., 2005 (Degterev et al., , 2008 . The second type were the reductants, in consideration of F16 increasing the level of intracellular oxidants. The third type were MPT inhibitors. The forth type were Gluc and ATP, for maintaining cellular ATP concentration.
ZVAD-fmk showed modest protective effect and enhanced cell viability at certain concentrations ( Figure 8A ). The only partial ZVAD-fmk protective effect might be the result that the cytotoxicity induced by F16 is extensive, and the cell death is a consecutive process. Only inhibited the caspases might not totally offset the antiproliferative effect of F16. In addition, the mitochondrion-centered apoptosis can be caspase-independent (Galluzzi et al., 2012) . Nec-1 was chosen in consideration that F16 could trigger necrosis in tumor cells under certain conditons (Fantin and Leder, 2004) . While Nec-1 did not increase the viability of SGC-7901 cells upon the treatment of F16 ( Figure 8B ), when it was tested on caspase-3-deficient MCF-7 cells, protective effect was observed (Supplementary Figure 6A) , verifying the occurrence of necrosis induced by F16.
The reductants showed partial but not striking protective effect ( Figure 8C and Supplementary Figure 6B ). This result was in accordance with the oxidation level recovery experiment. Besides, it might indicate that oxidative damage was not the major factor of cytotoxicity upon the treatment of F16.
The four chosen MPT inhibitors act in different manners. Cs A is the inhibitor of cyclophilin D, while ADP acts on the adenine nucleotide translocase (ANT) as reported by Crompton (1999) . Cyclophilin D and ANT are both the components of permeability transition pore (PTP). EDTA and RR take effects through decrease the concentration of Ca 2þ , since EDTA is a Ca 2þ chelator and RR can inhibit the release of Ca 2þ (Bae, 2003) .
At a certain concentration and a suitable incubation time, the PTP inhibitor Cs A could protect cells from the treatment of F16 to a certain content ( Figure 8D and Supplementary Figure 6C) . The similar results were observed following the treatment of ADP, EDTA or RR ( Figure 8E , Supplementary Figs. 6D and E) . The results verified that MPT was involved in F16-mediated cytotoxicity.
The previous experiments showed that F16 and PVI had uncoupling effects on mitochondria, thus might result in energetic breakdown in cells. We supplemented the medium with Gluc or ATP to find out if the damage upon the treatment of F16 could be prevented. Gluc had some effect but not as obvious as expected (Supplementary Figure 6F) . Fortunately, ATP almost completely recovered the cell viability decreased by F16 or PVI ( Figure 8F ). Although ATP also acts as a MPT inhibitor, its inhibiting effect is weaker than that of ADP (Zoratti and Szab o, 1995) . Since the protective performance of ATP was much better than that of ADP, the protection effect could not be merely attributed to the inhibition of MPT, but related to ATP directly serving as energy supply. This result validated the uncoupling effects of F16 and PVI. Furthermore, it was possible that the failure to produce ATP resulting in the decrease of ATP availability was the direct and major factor involving in toxicity upon the treatment of F16. Additionally, the occurrence of MPT, the release of cytochrome c and the activation of caspases might be subsequent events leading to cell damage.
DISCUSSION
Mitochondrial membrane permeabilization can be described as the rupture of mitochondrial membranes leads to their functional impairment as well as to the release of toxic mitochondrial IMS proteins into the cytosol. Long-lasting openings of the PTP complex lead to MPT with an abrupt increase in the inner mitochondrial membrane permeability to ions and low molecular mass solutes, provoking mitochondrial swelling. As the surface area of the inner membrane considerably exceeds that of the outer membrane, MPT eventually leads to MOMP with the loss of the outer mitochondrial membrane impermeability to proteins. Thus irreversible MOMP affecting most mitochondria within a single cell has multiple lethal consequences and activates a feed-forward circuit for the amplification of the apoptotic signal (Fulda et al., 2010; Galluzzi et al., 2012; Kroemer et al., 2007) .
In accordance with previous report, F16 selectively accumulated in mitochondria and induced a striking toxicity on tumor cells. Although PVI did not concentrated in mitochondria and not showed obvious cytotoxicity. But when directly incubated with isolated mitochondria, the effects caused by F16 and PVI were much similar. They caused change in mitochondrial ultrastructure, induced swelling, increased inner membrane permeabilization to H þ /K þ and changed mitochondrial membrane fluidity. Moreover, it was observed that PVI also acted as an uncoupler and affected mitochondrial respiration, like F16, resulting in decreased intracellular ATP level, DWm dissipation and the release of cytochrome c, indicating the occurrence of MPT.
The rescue experiments indicated that the addition of ATP was the most effective way to recover the cell viability decreased by F16. Therefore, we speculated that the decreased ATP availability induced by uncoupling was a major factor leading to cytotoxicity. Furthermore, since intracellular ATP level is a critical determinant for cells in undergoing apoptosis or necrosis (Leist et al., 1997) , the uncoupling effect may provide a reason for the dual ability of F16 to induce apoptosis and necrosis (Fantin and Leder, 2004) . Since PVI also acts as an uncoupler, the uncoupling effect of F16 can not be attributed to the depolarization caused by the accumulation of cations in mitochondrial matrix, instead it benefits from the common structure shared by F16 and PVI. In previous report, we have demonstrated that PVI has a better affinity to HSA compared with F16, indicating an possible adverse effect of positive charge on transport and metabolism (Wang et al., 2014) . In this study, we find out that uncoupling effect was a major factor leading to cytotoxicity induced by F16, and PVI with no positive charge is also characterized as an uncoupler. Miyata et al. (2013) have synthesized a derivative of MKT-077 with a neutral pyridine replacing cationic pyridinium moiety in MKT-077 resulting in improved clogP and enhanced blood-brain barrier penetrance as well as quick clearance from the kidney, thus the agent named YM-08 are suitable for use in the central nervous system. Therefore, it is reasonable to make a hypothesis that positive charge is not necessary and beneficial in all situations. In addition to being a promising anticancer agent, further investigations of F16 are still required to discover its potential.
SUPPLEMENTARY DATA
Supplementary data are available at Toxicological Sciences online.
FUNDING
National Natural Science Foundation of China (21673166, 21473125, 21225313) ; Bagui Scholar Program of Guangxi.
